The U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response, awarded a $740,000.00 definitive, firm-fixed-price contract to Jumpcode Genomics Inc. for CRISPR-powered next-generation sequencing (NGS)-based agnostic diagnostic capabilities under the Division of Research, Innovation, and Ventures (DRIVe) Easy Broad Agency Announcement (EZ-BAA). This contract, which has a period of performance through September 25, 2023, was awarded on a...
This is a $726,102 firm fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to The Regents of the University of California, San Francisco (UCSF) for clinical validation of a next-generation sequencing (NGS)-based diagnostic test for respiratory viral pathogens, including SARS-CoV-2. The contract is funded through ASPR's Division of Research, Innovation, and Ventures (DRIVe) and was competitively awarded without a set-aside. It includes two...
This is a $354,267.22 firm fixed price definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Grip Molecular Technologies Inc., a small disadvantaged business. The contract involves research and development of ultra-sensitive photonic integrated circuit detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza A antigens using graphene biosensors. The goal is to support the...
This is a $9,374,751 definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the Department of Health and Human Services, to Sherlock Biosciences, Inc., a for-profit company specializing in rapid, field-deployable molecular diagnostics based on CRISPR technology. The contract is for the development of a low-cost, point-of-need molecular test for influenza A and B that can utilize self-collected swab specimens. This contract...
<p>The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $379,984 firm fixed price purchase order to Precision Nanosystems US Inc. of South San Francisco, California. The purchase order is for the provision of NANOASSEMBLR NXGEN BLAZE instruments in support of coronavirus COVID-19 research and will run from September 30, 2022 through December 30, 2022. No applicable subcontractors were identified.</p>
This is a $53,620,678.50 firm fixed price contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Monogram Biosciences, Inc., a subsidiary of Laboratory Corporation of America Holdings. The contract is for the provision of high-throughput SARS-CoV-2 neutralizing antibody immunoassay services to evaluate variants and test human serum samples. This contract is not set aside for any specific socioeconomic...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded The Scripps Research Institute a $2,545,376 definitive cost-no-fee contract to perform Genomic Sequencing of SARS-CoV-2 to investigate local and cross-border emergence and spread using viral phylodynamics. The Scripps Research Institute will perform this work in La Jolla, California over a two-year period concluding in September 2024. The University of California, San Diego will provide...
This federal contract award is for the provision of Pacific Biosciences' proprietary reagent kits to support genomic research initiatives at the National Institute of Allergy and Infectious Diseases, which is part of the Department of Health and Human Services. The $11,864.64 firm fixed price purchase order has a completion date of July 3, 2024 and was awarded on April 4, 2024 to Pacific Biosciences of California, Inc., a manufacturer of specialized scientific equipment, reagents, and services...
This definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Qiagen, LLC is valued at approximately $598,000. Under the contract, Qiagen will perform research and development of the QIAstat-DX Respiratory SARS-CoV-2 Panel to aid in the mitigation of long-term effects of respiratory distress, as requested under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002. Work will be...
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $2.25 million firm fixed price purchase order to Cepheid, a subsidiary of Danaher Corporation, to provide testing site systems in support of COVID-19 response efforts. The contract runs from April 30, 2020 to September 25, 2020 for the delivery of products and services to test for the novel coronavirus at Cepheid's location in Sunnyvale, California. No subcontractors or set...